Health Highlights: March 29, 2022
Birth defects rise in babies born to men who took diabetes drug. Infants of men taking the common drug metformin may have a slightly increased risk, new Danish research shows. Read moreFDA review gives thumbs down to new ALS drug. Despite months of in…
Learn MoreCOVID Can Leave People With Lingering Nerve Damage
TUESDAY, March 29, 2022 (HealthDay News) — For many people, damage from COVID-19 continues well beyond the initial infection. A case in point: Pain, tingling and numbness in the hands and feet can occur for weeks or months afterward, a new study reve…
Learn MoreMore Balmy Summer Nights, Higher Heart Death Rate in Men
TUESDAY, March 29, 2022 (HealthDay News) — Warm summer nights may leave you tossing and turning in bed, but that could be the least of your worries. Just a slight rise in summer nighttime temperatures increases the risk of heart-related death for me…
Learn MoreWhat Works (and Doesn’t) to Raise Success Rate of IVF
TUESDAY, March 29, 2022 (HealthDay News) — Ultrasound guidance and soft catheters are among the measures that can be used during embryo transfer to help improve the chances of successful in-vitro fertilization (IVF), according to a British study.”It …
Learn MoreDepression Raises Stroke Risk for Heart Attack Survivors
TUESDAY, March 29, 2022 (HealthDay News) — Heart attack survivors with depression have an increased risk of stroke, and more research is needed to find out why, according to the authors of a new study.”There could be a multitude of depression-related…
Learn MoreAAD: Baricitinib Tops Placebo for Hair Regrowth in Alopecia Areata
MONDAY, March 28, 2022 (HealthDay News) — For adults with severe alopecia areata, oral baricitinib is superior to placebo with respect to hair regrowth at 36 weeks, according to a study published online March 26 in the New England Journal of Medicine…
Learn MoreStakes Are High Ahead of FDA Panel Vote on ALS Drug
MONDAY, March 28, 2022 (HealthDay News) — Advocacy groups are pressing U.S. federal regulators to fast-track approval of an experimental drug treatment for amyotrophic lateral sclerosis (ALS), with a decision expected this week.The push to approve th…
Learn MoreBiden Administration to Offer Second COVID-19 Boosters to Those 50+
MONDAY, March 28, 2021 (HealthDay News) — Despite not knowing how long another jab might provide protection, the Biden administration plans to offer a second COVID-19 booster shot to Americans 50 and older.Optional second boosters of the Pfizer or Mo…
Learn More